DSP Healthcare Fund vs Invesco India Pharma and Healthcare Fund
Direct Plan, Growth option · Data as on 29-10-2026
DSP Healthcare Fund is a Sectoral fund and Invesco India Pharma and Healthcare Fund is a Sectoral fund. DSP Healthcare Fund charges 0.76% a year and Invesco India Pharma and Healthcare Fund 3.30% (Direct plans). Their portfolios overlap 26.1%: they hold 5 of the same securities.
Invesco India Pharma and Healthcare Fund
Sectoral
- Expense ratio
- 3.30%
- NAV
- ₹9.66
Which is better, DSP Healthcare or Invesco India Pharma and Healthcare? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- DSP Healthcare costs less: 0.76% a year against 3.30% (Direct plans).
- DSP Healthcare fell less in its worst fall since 10-09-2026: −6.8% against −11.4%.
- DSP Healthcare holds 9.3% of the fund in foreign stocks; Invesco India Pharma and Healthcare 0.0%.
- DSP Healthcare is the larger fund: ₹3,750 Cr against ₹436 Cr.
- Their portfolios overlap 26.1%: 5 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | DSP Healthcare Fund | Invesco India Pharma and Healthcare Fund |
|---|---|---|
| Fund house | DSP Mutual Fund | Invesco Mutual Fund |
| Category | Sectoral | Sectoral |
| AUM | ₹3,750 Cr (30-09-2026) | ₹436 Cr (30-09-2026) |
| NAV | ₹50.24 (Direct) | ₹9.66 (Direct) |
| Expense ratio (Direct) | 0.76% | 3.30% |
| Expense ratio (Regular) | 2.06% | 5.19% |
| Riskometer | Very High | Very High |
| Benchmark | BSE Healthcare TRI | BSE Healthcare TRI |
| Launch date | 30-11-2018 | 01-09-2026 |
| Minimum investment | ₹100 | Not available |
| Lock in | None | None |
| Fund managers | Chirag Dagli | Aditya Khemani |
| Exit load | Exit load of 0.50% if redeemed within 1 month. | Exit load of 0.50%, if redeemed within 3 months. |
DSP Healthcare vs Invesco India Pharma and Healthcare: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| DSP Healthcare Fund (Direct) | −1.61% | +1.18% | +16.73% | +15.40% | +21.77% | +16.26% | -- |
| Invesco India Pharma and Healthcare Fund (Direct) | +0.73% | -- | -- | -- | -- | -- | -- |
| Sectoral average | −1.70% | -- | -- | -- | -- | -- | -- |
Category average: the average of the 20 Sectoral funds, same plan type.
DSP Healthcare vs Invesco India Pharma and Healthcare: Year-wise Returns
| Year | DSPDSP Healthcare | Invesco India Pharma andInvesco India Pharma and Healthcare | BSE Healthcare TRI |
|---|---|---|---|
| 2026to date | +15.40% | -- | +14.00% |
| 2025 | −4.55% | -- | −2.72% |
| 2024 | +42.61% | -- | +44.30% |
| 2023 | +36.80% | -- | +37.97% |
| 2022 | −6.50% | -- | −11.50% |
| 2021 | +25.11% | -- | +21.54% |
DSP Healthcare vs Invesco India Pharma and Healthcare: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of both
DSP Healthcare vs Invesco India Pharma and Healthcare: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | DSP Healthcare Fund (Direct) | Invesco India Pharma and Healthcare Fund (Direct) |
|---|---|---|
| Return (CAGR) | +22.57% | −23.45% |
| Standard deviation | 14.11% | 18.70% |
| Sharpe ratio | 1.23 | -1.54 |
| Sortino ratio | 1.77 | -2.20 |
| Maximum drawdown | −21.7% (23-03-2020) | −11.4% (23-10-2026) |
| Beta | 0.77 | 1.00 |
| Alpha | +7.48% | −8.00% |
From daily NAVs, 03-12-2018 to 29-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
DSP Healthcare Fund (Direct)
Invesco India Pharma and Healthcare Fund (Direct)
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| DSP Healthcare Fund (Direct) | −6.8% | 21-09-2026 | 23-10-2026 | Not yet | -- | −2.8% |
| Invesco India Pharma and Healthcare Fund (Direct) | −11.4% | 23-09-2026 | 23-10-2026 | Not yet | -- | −4.4% |
| BSE Healthcare TRI | −9.9% | 23-09-2026 | 23-10-2026 | Not yet | -- | −3.8% |
From daily values since 10-09-2026, the first day every fund has.
DSP Healthcare vs Invesco India Pharma and Healthcare: Portfolio Overlap
From each fund's latest monthly portfolio: DSP Healthcare Fund, September 2026; Invesco India Pharma and Healthcare Fund, September 2026
Holdings in common
- Overlap
- 26.1%
- Held by both
- 5
- Only in DSP Healthcare
- 22
- Only in Invesco India Pharma and Healthcare
- 8
| Security | % of DSP Healthcare | % of Invesco India Pharma and Healthcare |
|---|---|---|
| Sun Pharmaceutical Industries Limited | 7.44% | 8.99% |
| Sai Life Sciences Limited | 6.52% | 8.63% |
| Apollo Hospitals Enterprise Limited | 6.07% | 8.03% |
| Divi's Laboratories Limited | 4.17% | 7.85% |
| Manipal Health Enterprises Limited | 1.85% | 7.98% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 26.1% means 26.1% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in DSP Healthcare Fund
| Security | % of fund |
|---|---|
| IPCA Laboratories Limited | 8.13% |
| Cipla Limited | 7.18% |
| Gland Pharma Limited | 6.15% |
| Alkem Laboratories Limited | 4.75% |
| Cohance Lifesciences Limited | 3.79% |
Largest holdings only in Invesco India Pharma and Healthcare Fund
| Security | % of fund |
|---|---|
| Max Healthcare Institute Limited | 9.58% |
| Global Health Limited | 7.00% |
| Dr Agarwals Health Care Limited | 6.32% |
| Corona Remedies Limited | 6.13% |
| Torrent Pharmaceuticals Limited | 4.93% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | DSP Healthcare | Invesco India Pharma and Healthcare |
|---|---|---|
| Equity | 93.3% | 87.0% |
| Debt | 0.0% | 0.0% |
| Cash and others | 6.7% | 13.0% |
Market cap of stocks
| Market cap | DSP Healthcare | Invesco India Pharma and Healthcare |
|---|---|---|
| Large Cap | 24.9% | 29.8% |
| Mid Cap | 14.2% | 16.4% |
| Small Cap | 42.7% | 32.8% |
| Foreign stocks | 9.3% | 0.0% |
| Not on AMFI's list | 2.2% | 8.0% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | DSP Healthcare | Invesco India Pharma and Healthcare |
|---|---|---|
| Pharmaceuticals & Biotechnology | 65.8% | 41.4% |
| Healthcare Services | 17.8% | 45.6% |
| Healthcare Equipment & Supplies | 7.5% | 0.0% |
| Foreign Security | 1.1% | 0.0% |
| Insurance | 1.0% | 0.0% |
The six largest sectors of each fund's stocks, % of the fund.
DSP Healthcare vs Invesco India Pharma and Healthcare: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | DSP Healthcare Fund | Invesco India Pharma and Healthcare Fund |
|---|---|---|
| Total expense ratio (Direct) | 0.76% | 3.30% |
| Base expense ratio (Direct) | 0.54% | 0.50% |
| Total expense ratio (Regular) | 2.06% | 5.19% |
| Base expense ratio (Regular) | 1.65% | 2.10% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare DSP Healthcare with
Compare Invesco India Pharma and Healthcare with
DSP Healthcare Fund vs Invesco India Pharma and Healthcare Fund: Frequently Asked Questions
What is the difference between DSP Healthcare Fund and Invesco India Pharma and Healthcare Fund?
DSP Healthcare Fund is a Sectoral fund, Invesco India Pharma and Healthcare Fund is a Sectoral fund, run by DSP Mutual Fund and Invesco Mutual Fund. Their portfolios overlap 26.1%. DSP Healthcare Fund charges 0.76% a year and Invesco India Pharma and Healthcare Fund 3.30%.
Which has the lower expense ratio, DSP Healthcare Fund or Invesco India Pharma and Healthcare Fund?
DSP Healthcare Fund charges less: 0.76% a year against 3.30%. These are the Direct plans' total expense ratios reported to AMFI.
How much do DSP Healthcare Fund and Invesco India Pharma and Healthcare Fund overlap?
26.1%. They hold 5 of the same securities, the largest shared ones being SUNPHARMA, SAILIFE, APOLLOHOSP. From each fund's latest monthly portfolio.
Which is riskier, DSP Healthcare Fund or Invesco India Pharma and Healthcare Fund?
On SEBI's riskometer, DSP Healthcare Fund is rated Very High and Invesco India Pharma and Healthcare Fund Very High. Over their common history, the standard deviation of daily returns was 14.11% and 18.70% a year.
Can I invest in both DSP Healthcare Fund and Invesco India Pharma and Healthcare Fund?
Yes. 26.1% of each fund's money sits in the same holdings, so some of the two investments would move together.
Who manages DSP Healthcare Fund and Invesco India Pharma and Healthcare Fund?
DSP Healthcare Fund: Chirag Dagli. Invesco India Pharma and Healthcare Fund: Aditya Khemani.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.